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Abstract
To determine the aetiology, clinical characteristics and
outcome of patients admitted with pulmonary renal
syndrome (PRS). This retrospective analysis was
conducted at Aga Khan University Hospital from 2011
to 2015. A total of 17 adult patients admitted with PRS
were included and followed up for a period of one year
for the outcome of PRS as recovery, dialysis dependency
or death. Anti-neutrophil cytoplasmic antibody (ANCA)
associated vasculitis (AAV) was found to be the single
most frequent cause in 13 (76.4%) patients. The
co mmonest caus e o f  AAV was  found to  be
Granulomatous polyangitis (GPA) in 10 (58.8%) followed
by Microscopic angitis in 3 (17.6%) patients. Around 12
(70.5%) patients survived, 11 (64.7%) recovered while 1
patient remained dialysis dependent. Mortality rate was
29.4% and all these patients had severe alveolar
haemorrhages. None of our patient died or relapsed
during one year follow up.
Keywords: Pulmonary renal syndrome (PRS), diffuse
alveolar haemorrhages (DAH), acute kidney injury (AKI),
Antineutrophil cytoplasmic autoantibody (ANCA)
associated vasculitis,  anti-glomerular basement
membrane (GBM) disease, systemic lupus erythematosus
(SLE).
Introduction
The term pulmonary renal syndrome (PRS) was first
described by Good pasture in 1919.1 PRS is characterized
b y  t h e  o c c u r r e n c e  o f  r a p i d l y  p r o g r e s s i v e
glomerulonephritis (RPGN) and diffuse alveolar
haemorrhages (DAH) simultaneously secondary to an
underlying autoimmune cause.1 The parallel histologic
findings include focal and segmental necrotizing
glomerulonephritis with crescents on renal biopsy and
alveolar capillaritis on lung biopsy. Many common clinical
conditions can mimic PRS, nonetheless a high index of
suspicion for PRS is critical as early diagnosis and
t r e a t m e n t  r e m a r k a b l y  i m p r o v e s  o u t c o m e .
PRS can be caused by a number of diseases but the most
common causes include anti-neutrophil cytoplasmic
antibody (ANCA) associated vasculitis (AAV), anti-
glomerular basement membrane (anti GBM) disease and
systemic lupus erythematosus (SLE).2 These diseases
account for  about  70-80 % causes of  P RS.3 , 4
The prevalence and the outcome data for the causes
that lead to PRS is available, however, the exact incidence
of PRS as a syndrome is limited to few studies because
of rarity of condition. The causes of PRS in Pakistan might
be the same as in rest of the world but due to lack of
awareness and education, patients usually present late
to the hospital so the outcome may differ. This analysis
was done to find out the clinical presentation, aetiology
and outcome of PRS in our patient population.
Patients and Methods
This retrospective analysis was conducted at Aga Khan
University Hospital (AKUH), Karachi, Pakistan from 2011
to2015. Following patients with acute kidney injury (AKI)
were included;
1. AKI with simultaneous pulmonary involvement along
with positive ANCA (P-ANCA or C-ANCA) or anti GBM
antibodies OR
2. AKI with simultaneous pulmonary involvement along
with positive antinuclear antibody (ANA), anti-double
stranded (dsDNA) or both OR
3. AKI with simultaneous pulmonary involvement along
wi th  rena l  b iopsy ( i f  do ne ) evidence o f
a. Focal necrotizing glomerulonephritis with linear,
granular or no deposit on immunofluorescence
(IF) OR
b. Crescentic Glomerulonephritis with linear,
granular or no deposit on IF OR
c. Mesangio-capillary Glomerulonephritis with
deposits of immunoglobulin in capillary wall,
sub endothelium and/ or mesangium on IF
AKI was defined by Kidney Diseases Improving Global
Outcome (KDIGO) criteria5 as a rise in serum creatinine
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of  0.3 mg/dl from the baseline within 48 hours or a
rise in creatinine 1.5 times from the baseline within the
last 7 days.5
Baseline serum creatinine was retrieved from the
outpatient records within the last 3 months. When not
available, patients were considered to have AKI when
the presentation was acute with active urine sediment
and normal sized kidneys on ultrasound.
Pulmonary involvement was defined by the presence of
any two or more of the following:
a. Respiratory symptoms including either cough,
s h o r t n e s s  o f  b re a t h  o r  ha e m op t y s is
b. D i re c t  v i su a l i z at i o n  o f  b l e e d in g  v i a
bronchoscopy or the presence of hemosiderin
laden macrophages
c. Unilateral or bilateral new alveolar infiltrates on
CXR
d.  Unexplained Hb of < 10g/dl or haematocrit
30%
The patients were followed till one year and the outcome
of the patients was recorded as:
1. Recovered
2. Died
3. Dialysis dependent
Recovery was complete if serum creatinine was
normalized or reached baseline, or partial when there
was a reduction in serum creatinine from the admission
creatinine and patient  became dialys is f ree.
Data was collected after approval from hospital ethical
review committee. All data was entered and analysed
using SPSS 19 and mean, median and percentage was
calculated to describe the data.
Results
A total of 17 patients with PRS were managed at our
institution from 2011 to 2015. Base line characteristics
of patients are shown in Table 1. The most frequent cause
of PRS came was granulomatous polyangitis (GPA) as
shown in Table 2. Renal biopsy was done in 7 patients.
A l l  patient s  were found to have cresce nt ic
glomerulonephritis (GN). Linear deposition of IgG along
glomerular basement membrane was found in 2 patients
while in rest of the patients immunofluorescence was
negative.
All patients were treated with systemic steroids. For
i n d u c t i o n  t h e r a p y,  i n t r a v e n o u s  ( I V )  p u l s e
methylprednisolone was given to 15 (88.23%) patients,
whereas oral deltacortil at 1mg/kg was given to 2
patients, cyclophosphamide was given to 12 patients (8
patients received oral and 4 patients received IV), IV
rituximab was given to 2 patients while in 3 patients
immunosuppressive other than methylprednisolone
could not be given because they died early within 2-3
days of  hospital  stay  due to severe alveolar
haemorrhages. Plasmapheresis and haemodialysis
sessions are shown in Table 1. During the study period,
IV methylprednisolone was followed by oral prednisolone
at 1 mg/kg which was tapered over 3 months. During
maintenance phase 7 patients received azathioprine
w he reas  4  received M yco pheno late  M ofe ti l .
Outcome of patients according to the aetiology of PRS
is shown in Table 2. We found 100% mortality in patients
with SLE. In patients who recovered, 4(36.3%) patients
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Variables n (%)
Age (mean) 45.5 ± 15.3 years
Sex
Female 13(76.5)
Co morbid
Asthma 4(23.5)
Ischemic heart disease 3 (17.6)
SLE* 2(11.7)
Diabetes mellitus 1 (5.9)
Hypertension 1 (5.9)
Symptoms at presentation
Weakness 17 (100)
Shortness of breath 13 (76.5)
Fever 10 (58.8)
Hemoptysis 9 (52.9)
Nausea/ vomiting 7 (41.2)
Cough 6 (35.3)
Oliguria 5 (29.4)
Edema 2 (11.8)
CXR findings
Bi-alveolar infiltrates 13 (76.5)
Un-alveolar infiltrates 1 (5.9)
Nodular infiltrates 2 (11.8)
Consolidation 2 (11.8)
Cavitary lesions 1 (5.9)
Creatinine on admission mg/dl[medianIQR] 3.5 (1.1- 12)
Haematocrit on admission g/dl[medianIQR] 24.5 (16- 34.7)
Hospital course
Patients requiring dialysis 5 (29.4)
< 2 weeks 3 (17.6)
2-6 weeks 1 (5.9)
>6 weeks 1 (5.9)
Plasmaphresis 10 (58.8)
< 5 sessions 3 (17.6)
5-10 sessions 7 (41.2)
Non- invasive mechanical ventilation 7 (41.2)
Intensive care unit/ Mechanical ventilation 9 (52.9)
Vasopressors/ septic shock 7 (41.1)
SLE* systemic lupus erythematosus.
Table-1: Base line characteristics of patients with pulmonary renal syndrome.
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required haemodialysis and 4(36.3%) patients required
ventilator support. None of the patients relapsed during
one year follow up.
At one year follow up, serum creatinine reached < 1.2
mg/dl in 5 (45.4%) patients with GPA and 1 patient with
anti GBM disease. In the remaining 5 patients (1 with
MPA and 4 with GPA) the reduction in serum creatinine
was > 50% from the admission creatinine but did not
reach baseline.
Discussion
PRS is a fulminating condition that should be promptly
diagnosed and treated to prevent mortality and to
preserve renal functions. We performed this retrospective
case analysis and found AAV (76%) as the most frequent
cause of PRS. Most of the patients who present with
RPGN have renal limited disease. Pulmonary involvement
along with RPGN is a rare entity and data on the aetiology
and outcome is limited. AAV and GPS are rare disorders
with an incidence of 10 cases/million and 1 case/million
respectively.6 In our study, GPA (58.8%) was found to be
the leading cause of AAV followed by MPA. This is in
comparison with another study by Hugh et al who found
AAV as the leading cause (71%) with equal number of
GPA and MPA.4 Another study by Saxena et al found AAV
in 70% patients with PRS.7 In contrast to our results,
Srinivas et al from India found SLE (53.8%) as the leading
cause of PRS in critically ill patients8 whereas, we could
find only 2 (11.7%) patients of SLE presenting with PRS
and both came with catastrophic APLA. Anti GBM disease
is a very rare disorder and was found in only 2 patients
and this  is  comparable to other studies.4 , 7 , 8
Our study revealed a mortality rate of 29.4% which is in
contrast to another study by Saxena et al which reported
an early mortality of 12%.7 In another survey by Hugh
et al, mortality at one month was found to be 35% which
is close to our mortality rate. Other studies have reported
a very high mortality rate of 50-60% in PRS patients
requiring ventilator support.8,9 In this study the most
common cause of death was severe respiratory distress
followed by nosocomial infection.10 In another study
from India, mortality was 71.4% in SLE patients with PRS
and majority of the patients died within a week of
admission secondary to severe respiratory distress and
infection.8 GPS is also a rare condition with poor outcome.
In one case series of 67 patients, dialysis dependency or
death occurred in about 90% of patients with GPS.11
In our study, 12 (70%) patients survived the acute phase
though one patient remained dialysis dependent. The
patients who recovered had a reasonable outcome at
one year with regard to both longevity of life and
preservation of renal functions as none of our patients
relapsed during one year follow up.
Conclusion
We found GPA the commonest form of PRS with relatively
better outcome. Mortality is significantly higher in
patients with PRS who develop respiratory failure and
require ventilator support. Further large prospective
studies are needed to outline the aetiology and outcome
of PRS from Pakistan.
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